Recombinant human parathyroid hormone
- Status:
- Do Not Prescribe (DNP)
- Decision Date:
- April 2020
Comments
Recombinant human parathyroid hormone for treating hypoparathyroidism (NICE TA625) has been terminated therefore it has been classified as
DO NOT PRESCRIBE (DNP) (Decision date - June 2020)
search again